Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
presentation

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia


This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse. ALL is the most common cancer in children and shows extensive genetic intra-tumoral heterogeneity. This heterogeneity may be the underlying reason for an incomplete response to treatment and for the development of relapse. Data from this study provides information about the sensitivity of each leukemia clone to therapy and about how relapse can develop. Moreover, the results point toward the feasibility to detect minor clinically relevant leukemia clones at diagnosis or during early days of treatment in ALL.

The main focus of this webinar will be:
– Introduction of the Tapestri Platform from Mission Bio for targeted single-cell DNA sequencing

– Presentation of a novel custom panel covering the 300 most mutated genomic regions in ALL

– Insights into the clonal architecture of pediatric T-ALL, lessons learned from the first 16 samples processed with this custom ALL panel





presentation
Precision Over Bulk
presentation
Unlocking the Power of Single-Cell DNA Analysis with Simple Software
presentation
Single-Cell DNA Analysis: Resolving Tumor Heterogeneity with Implications for Dynamic Therapy
presentation
The Next Era in Single-Cell Genomics and Precision Medicine
REQUEST QUOTE